Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.

It’s often diagnosed at a late stage. But with a new blood test, scientists believe that survival rate could soar.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by ...

US-based biotechnology company Imunon has reported positive results from its Phase II OVATION 2 trial of IMNN-001 for ovarian ...

Corcept Therapeutics’ relacorilant, a selective glucocorticoid receptor antagonist (SGRA), is emerging as a novel therapeutic ...

This week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

A Danish research team has cracked the full biosynthesis of Taxol enabling cheaper and eco-friendly production in yeast.

Around one in 10 women will develop ovarian cysts at some point during their lives, and while the prospect of a cyst growing ...